Table 5.
The CK (U/L) and AST (U/L) activities (mean ± SD) in individual groups of horses during the study.
| Blood Sample Collection | ||||
|---|---|---|---|---|
| Group | 0 | 1 | 2 | 3 |
| G-placebo CK AST |
181.0 ± 34.9 297.3 ± 50.5 |
180.3 ± 26.3 296.1 ± 47.0 |
218.2 ± 34.1 314.3 ± 43.8 |
204.7 ± 35.3 295.2 ± 40.8 |
| G-CoQ10 CK AST |
295.6 ± 113.5 350.1 ± 76.7 |
284.5 ± 110.3 356.6 ± 88.7 |
304.2 ± 115.0 372.2 ± 89.1 |
310.7 ± 126.6 346.1 ± 76.8 b |
| G-Vit. E CK AST |
225.8 ± 100.2 328.3 ± 87.6 |
242.9 ± 77.5 327.4 ± 76.1 |
267.7 ± 90.4 331.6 ± 74.6 |
256.4 ± 91.4 326.3 ± 71.3 |
| G-CoQ10 + Vit. E CK AST |
184.6 ± 51.6 293.8 ± 65.1 |
271.7 ± 121.3 309.8 ± 80.1 |
391.2 ± 175.3 328.2 ± 89.9 |
304.3 ± 167.4 317.5 ± 125.3 |
b p < 0.05 compared to blood collection time 2 (within group comparison). 0, before adding antioxidant supplements; 1, before acute moderate exercise; 2, immediately after acute moderate exercise; 3, 24 h after acute moderate exercise; G-placebo, control group of horses supplemented with placebo; G-CoQ10, group of horses supplemented with CoQ10; G-Vit. E, group of horses supplemented with vitamin E; G-CoQ10 + Vit. E, group of horses supplemented with combination of CoQ10 and vitamin E; CK, creatine kinase; AST, aspartate aminotransferase.